Axogen, Inc. Common Stock (AXGN) is a publicly traded Healthcare sector company. As of September 1, 2026, AXGN trades at $50.50 with a market cap of $2.77B and a P/E ratio of -148.99. AXGN moved -0.51% today. Year to date, AXGN is +55.09%; over the trailing twelve months it is +214.50%. Its 52-week range spans $9.22 to $52.91. Analyst consensus is strong buy with an average price target of $55.86. Rallies surfaces AXGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AXGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $50.50 |
| Market Cap | $2.77B |
| P/E Ratio | -148.99 |
| EPS | $-0.34 |
| Dividend Yield | 1.00% |
| 52-Week High | $52.91 |
| 52-Week Low | $9.22 |
| Volume | 4.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $225.21M |
| Net Income | $-15.70M |
| Gross Margin | 74.31% |
7 analysts cover AXGN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $55.86.